Splice variants of RAS—translational significance

por Rásó, Erzsébet
Publicado 2020

The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma

por Barbai, Tamás, Fejős, Zsuzsanna, Puskas, Laszlo G., Tímár, József, Rásó, Erzsébet
Publicado 2015

Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression

por Bánky, Balázs, Rásó-Barnett, Lívia, Barbai, Tamás, Tímár, József, Becságh, Péter, Rásó, Erzsébet
Publicado 2012

Demonstration of a Melanoma-Specific CD44 Alternative Splicing Pattern That Remains Qualitatively Stable, but Shows Quantitative Changes during Tumour Progression

por Raso-Barnett, Livia, Banky, Balazs, Barbai, Tamas, Becsagh, Peter, Timar, Jozsef, Raso, Erzsebet
Publicado 2013

Frequent KIT mutations in skin lesions of patients with BRAF wild-type Langerhans cell histiocytosis

por Tóth, Béla, Kiss, Norbert, Hársing, Judit, Kárpáti, Sarolta, Csomor, Judit, Bödör, Csaba, Tímár, József, Rásó, Erzsébet
Publicado 2020

Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy

por Ladányi, Andrea, Rásó, Erzsébet, Barbai, Tamás, Vízkeleti, Laura, Puskás, László G., Kovács, Szonja A., Győrffy, Balázs, Tímár, József
Publicado 2022

EGFR Protein Expression in KRAS Wild-Type Metastatic Colorectal Cancer Is Another Negative Predictive Factor of the Cetuximab Therapy

por Uhlyarik, Andrea, Piurko, Violetta, Papai, Zsuzsanna, Raso, Erzsebet, Lahm, Erika, Kiss, Edina, Sikter, Marta, Vachaja, Jozsef, Kenessey, Istvan, Timar, Jozsef
Publicado 2020

Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential Diagnosis

por Somorácz, Áron, Kuthi, Levente, Micsik, Tamás, Jenei, Alex, Hajdu, Adrienn, Vrabély, Brigitta, Rásó, Erzsébet, Sápi, Zoltán, Bajory, Zoltán, Kulka, Janina, Iványi, Béla
Publicado 2019

Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, mult...

por Markóczy, Zsolt, Sárosi, Veronika, Kudaba, Iveta, Gálffy, Gabriella, Turay, Ülkü Yilmaz, Demirkazik, Ahmet, Purkalne, Gunta, Somfay, Attila, Pápai-Székely, Zsolt, Rásó, Erzsébet, Ostoros, Gyula
Publicado 2018

The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation

por Radeczky, Peter, Megyesfalvi, Zsolt, Laszlo, Viktoria, Fillinger, Janos, Moldvay, Judit, Raso, Erzsebet, Schlegl, Erzsebet, Barbai, Tamas, Timar, Jozsef, Renyi-Vamos, Ferenc, Dome, Balazs, Hegedus, Balazs
Publicado 2021

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis

por Lohinai, Zoltan, Klikovits, Thomas, Moldvay, Judit, Ostoros, Gyula, Raso, Erzsebet, Timar, Jozsef, Fabian, Katalin, Kovalszky, Ilona, Kenessey, István, Aigner, Clemens, Renyi-Vamos, Ferenc, Klepetko, Walter, Dome, Balazs, Hegedus, Balazs
Publicado 2017

EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas

por Nelhűbel, Györgyi A., Cserepes, Mihály, Szabó, Balázs, Türk, Dóra, Kárpáti, Adél, Kenessey, István, Rásó, Erzsébet, Barbai, Tamás, Hegedűs, Zita, László, Viktória, Szokol, Bálint, Dobos, Judit, Őrfi, László, Tóvári, József
Publicado 2021

EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer

por Cserepes, Mihály, Nelhűbel, Györgyi A., Meilinger-Dobra, Mónika, Herczeg, Adrienn, Türk, Dóra, Hegedűs, Zita, Svajda, Laura, Rásó, Erzsébet, Ladányi, Andrea, Csikó, Kristóf György, Kenessey, István, Szöőr, Árpád, Vereb, György, Remenár, Éva, Tóvári, József
Publicado 2022

Polyunsaturated fatty acids synergize with lipid droplet binding thalidomide analogs to induce oxidative stress in cancer cells

por Puskás, László G, Fehér, Liliána Z, Vizler, Csaba, Ayaydin, Ferhan, Rásó, Erzsébet, Molnár, Eszter, Magyary, István, Kanizsai, Iván, Gyuris, Márió, Madácsi, Ramóna, Fábián, Gabriella, Farkas, Klaudia, Hegyi, Péter, Baska, Ferenc, Ózsvári, Béla, Kitajka, Klára
Publicado 2010

KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy

por Ghimessy, Áron Kristof, Gellert, Áron, Schlegl, Erzsebet, Hegedus, Balazs, Raso, Erzsebet, Barbai, Tamas, Timar, Jozsef, Ostoros, Gyula, Megyesfalvi, Zsolt, Gieszer, Balazs, Moldvay, Judit, Renyi-Vamos, Ferenc, Lohinai, Zoltan, Hoda, Mir Alireza, Klikovits, Thomas, Klepetko, Walter, Laszlo, Viktoria, Dome, Balazs
Publicado 2019